562 related articles for article (PubMed ID: 20877357)
1. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
2. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
5. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
6. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
7. Genetic heterogeneity and cancer drug resistance.
Turner NC; Reis-Filho JS
Lancet Oncol; 2012 Apr; 13(4):e178-85. PubMed ID: 22469128
[TBL] [Abstract][Full Text] [Related]
8. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
Wooten DJ; Quaranta V
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
[TBL] [Abstract][Full Text] [Related]
9. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
10. A population genetics perspective on the determinants of intra-tumor heterogeneity.
Hu Z; Sun R; Curtis C
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
[TBL] [Abstract][Full Text] [Related]
11. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
Lee AJ; Swanton C
Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
[TBL] [Abstract][Full Text] [Related]
12. The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.
Brioli A; Melchor L; Cavo M; Morgan GJ
Br J Haematol; 2014 May; 165(4):441-54. PubMed ID: 24580032
[TBL] [Abstract][Full Text] [Related]
13. Integrating evolutionary dynamics into cancer therapy.
Gatenby RA; Brown JS
Nat Rev Clin Oncol; 2020 Nov; 17(11):675-686. PubMed ID: 32699310
[TBL] [Abstract][Full Text] [Related]
14. Constraints in cancer evolution.
Venkatesan S; Birkbak NJ; Swanton C
Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
[TBL] [Abstract][Full Text] [Related]
15. Catch my drift? Making sense of genomic intra-tumour heterogeneity.
Sottoriva A; Barnes CP; Graham TA
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):95-100. PubMed ID: 28069394
[TBL] [Abstract][Full Text] [Related]
16. Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution.
Venkatesan S; Swanton C; Taylor BS; Costello JF
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28289245
[TBL] [Abstract][Full Text] [Related]
17. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
[TBL] [Abstract][Full Text] [Related]
18. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
19. Translational implications of tumor heterogeneity.
Jamal-Hanjani M; Quezada SA; Larkin J; Swanton C
Clin Cancer Res; 2015 Mar; 21(6):1258-66. PubMed ID: 25770293
[TBL] [Abstract][Full Text] [Related]
20. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.
Aktipis CA; Kwan VS; Johnson KA; Neuberg SL; Maley CC
PLoS One; 2011; 6(11):e26100. PubMed ID: 22125594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]